International Analysis of Electronic Health Records of Children and Youth Hospitalized With COVID-19 Infection in 6 Countries

This cohort study aims to describe international hospitalization trends and key epidemiological and clinical features of children and youth with COVID-19.

[1]  Jeffrey S. Morris,et al.  International Comparisons of Harmonized Laboratory Value Trajectories to Predict Severe COVID-19: Leveraging the 4CE Collaborative Across 342 Hospitals and 6 Countries: A Retrospective Cohort Study , 2020, medRxiv.

[2]  Leora I. Horwitz,et al.  Assessment of Racial/Ethnic Disparities in Hospitalization and Mortality in Patients With COVID-19 in New York City , 2020, JAMA network open.

[3]  Simon M. Lin,et al.  Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States. , 2020, JAMA pediatrics.

[4]  J. Rigdon,et al.  Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker use during coronavirus disease 2019: beyond confounding. , 2020, Journal of hypertension.

[5]  Samantha K. Brenner,et al.  Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19. , 2020, JAMA internal medicine.

[6]  Jason W. Moore,et al.  Validation of a Derived International Patient Severity Phenotype to Support COVID-19 Analytics from Electronic Health Record Data , 2020, medRxiv.

[7]  Jessica S. Brown,et al.  SARS-CoV-2-Associated Deaths Among Persons Aged <21 Years - United States, February 12-July 31, 2020. , 2020, MMWR. Morbidity and mortality weekly report.

[8]  S. Kalnicki,et al.  Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York , 2020, JAMA network open.

[9]  Sohan Seth,et al.  Clinical characteristics of children and young people admitted to hospital with covid-19 in United Kingdom: prospective multicentre observational cohort study , 2020, BMJ.

[10]  L. Saiman,et al.  A Pediatric Infectious Disease Perspective of SARS-CoV-2 and COVID-19 in Children. , 2020, Journal of the Pediatric Infectious Diseases Society.

[11]  H. Krumholz,et al.  Agile analytics to support rapid knowledge pipelines , 2020, npj Digital Medicine.

[12]  K. Wilson,et al.  COVID-19 and multisystem inflammatory syndrome in children and adolescents , 2020, The Lancet Infectious Diseases.

[13]  Meleah D. Boyle,et al.  Racial and/or Ethnic and Socioeconomic Disparities of SARS-CoV-2 Infection Among Children , 2020, Pediatrics.

[14]  L. Rubin,et al.  Early Experience of COVID-19 in a US Children's Hospital , 2020, Pediatrics.

[15]  M. Raux,et al.  Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with SARS-CoV-2 pneumonia: an opportunistic retrospective analysis , 2020, Critical Care.

[16]  J. Gerber,et al.  The Epidemiology of SARS-CoV-2 in a Pediatric Healthcare Network in the United States. , 2020, Journal of the Pediatric Infectious Diseases Society.

[17]  Adam J. Schweickert,et al.  Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York. , 2020, JAMA pediatrics.

[18]  Soumitra Sengupta,et al.  Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series , 2020, BMJ.

[19]  G. Lippi,et al.  Laboratory abnormalities in children with mild and severe coronavirus disease 2019 (COVID-19): A pooled analysis and review , 2020, Clinical Biochemistry.

[20]  M. Cabana,et al.  Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City , 2020, The Journal of Pediatrics.

[21]  Florence T. Bourgeois,et al.  Inclusion of Children in Clinical Trials of Treatments for Coronavirus Disease 2019 (COVID-19). , 2020, JAMA pediatrics.

[22]  Brett K. Beaulieu-Jones,et al.  International electronic health record-derived COVID-19 clinical course profiles: the 4CE consortium , 2020, npj Digital Medicine.

[23]  T. Jodlowski,et al.  Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. , 2020, JAMA.

[24]  M. Brandão,et al.  Clinical manifestations of children with COVID‐19: A systematic review , 2020, medRxiv.

[25]  Mario Plebani,et al.  Laboratory abnormalities in patients with COVID-2019 infection , 2020, Clinical chemistry and laboratory medicine.

[26]  Finale Doshi-Velez,et al.  Big Data in the Assessment of Pediatric Medication Safety , 2020, Pediatrics.

[27]  C. Forrest,et al.  Using Electronic Health Record Data to Rapidly Identify Children with Glomerular Disease for Clinical Research. , 2019, Journal of the American Society of Nephrology : JASN.

[28]  C. Forrest,et al.  Strengthening the Evidence Base for Pediatric Medical Devices Using Real-World Data. , 2019, The Journal of pediatrics.

[29]  Arvind Satyanarayan,et al.  Altair: Interactive Statistical Visualizations for Python , 2018, J. Open Source Softw..

[30]  C. Forrest,et al.  Being Overweight or Obese and the Development of Asthma , 2018, Pediatrics.

[31]  N. Adler,et al.  Using Electronic Health Records for Population Health Research: A Review of Methods and Applications. , 2016, Annual review of public health.

[32]  T. Klaukka,et al.  Evolution of paediatric off-label use after new significant medicines become available for adults: a study on triptans in Finnish children 1994-2007. , 2011, British journal of clinical pharmacology.

[33]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .